2025-523558-14-00
Recruiting
Phase 1
A Phase 1 Study of AIR-001 in Adults with AATD.
Airna Corp.7 sites in 4 countries19 target enrollmentStarted: April 1, 2026Last updated:
ConditionsAlpha-1 Antitrypsin Deficiency
Overview
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Airna Corp.
- Enrollment
- 19
- Locations
- 7
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Kristina Storey
Scientific
Airna Corp.
Study Sites (7)
Loading locations...
Similar Trials
Recruiting
Phase 1
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)NCT07431112AIRNA Corporation54
Recruiting
Phase 2/3
The safety and efficacy of Alpha-1 Antitrypsin (AAT) for the prevention of graft‑versus-host disease (GVHD) in patients receiving hematopoietic cell transplant.2024-511164-92-00CSL Behring LLC45
Recruiting
Not Applicable
A Study of AK138D1 in Advanced Malignant TumorsNCT07281326Akeso200
Active, not recruiting
Phase 3
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)2023-506873-36-00Alector LLC79
Recruiting
Phase 1
Study in Advanced Solid Tumor PatientsNCT07300943Callio Therapeutics306